Targeting Protein Restores Aging Blood Cells, UF Researchers Find
UF researchers have discovered a way to prevent chronic inflammation that harms blood stem cells in the bone marrow, weakens the immune system, and reduces chemotherapy effectiveness.
UF Microbiome Expert Named UF Distinguished Professor
Christian Jobin, Ph.D., who leads innovative research on how the microbiome affects cancer, inflammation, and drug responses, has been named a UF Distinguished Professor, which is the highest faculty honor awarded at UF.
Common Food Poison Toxin Speeds Colon Cancer Spread, UF Researchers Find
A toxin in the bacteria that’s one of the most common causes of foodborne illness accelerates the spread of colorectal tumors to other parts of the body, a study led by UF researchers and international collaborators has found.
Carolyn M. Tucker, Ph.D., receives President’s Lifetime Achievement Award
In recognition of her work to build healthier communities and provide hundreds with power over cancer, Carolyn M. Tucker has received a 2024 President’s Lifetime Achievement Award from the office of U.S. President Joe Biden.
NCI Grant Supports UF Health Cancer Center Epigenetics Research
Richard Bennett, Ph.D., a research associate professor in the Division of Hematology/Oncology in the UF College of Medicine, has received a prestigious five-year, $850,000 grant from the National Cancer Institute (NCI) to support research investigating epigenetic mechanisms of cancer.
UF-Developed Genetic Score Improves Outcomes by Personalizing Leukemia Therapy
Using patients’ own genetics to tailor their chemotherapy regimens appears to improve outcomes in children with acute myeloid leukemia, a pediatric cancer for which treatment has gone unchanged for 50 years, a new University of Florida Health-led study shows.
MBI Researchers to Test Novel Treatments for Medulloblastoma
University of Florida researchers have received approval from the Food and Drug Administration to test two new experimental therapies in first-ever human clinical trials for a subtype of medulloblastoma, the most common pediatric malignant brain tumor.
UF-Developed mRNA Vaccine Triggers Fierce Immune Response To Fight Malignant Brain Tumor
In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine developed at the University of Florida quickly reprogrammed the immune system to attack glioblastoma, the most aggressive and lethal brain tumor.
UF Health Cancer Center to Launch Mobile Mammography Unit and Expand Access to Care
With a $1.5-million grant awarded through University of Florida President Ben Sasse’s strategic funding initiative, the UF Health Cancer Center will launch an initiative called Expanding Access to Breast Cancer Screening in North Central Florida. A mobile mammography unit will be outfitted with leading-edge technology to bring services directly to the community. The unit will be the first of its kind in North Central Florida – a region larger than Massachusetts, Rhode Island, and Connecticut combined.
President’s Office Announces $10.9 Million for Third Round of Strategic Funding Awardees
UF President Ben Sasse announced a third round of strategic funding, which will see $10.9 million spread across 10 new projects aimed at solidifying UF's standing as a national research leader.
